Web Exclusives

New safety information for Invirase

The U.S. Food and Drug Administration announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir).…

Abbott withdraws Meridia from market

On Oct. 8, Abbott Laboratories voluntarily withdrew its weight loss drug Meridia (sibutramine) from the market in response to a request from the U.S.…

How to revive the FDA

The Oct. 6 New England Journal of Medicine includes a perspective on how to “revive” the U.S. Food and Drug Administration. Read it here.

AHRQ releases new guide for patients

The Agency for Healthcare Research and Quality (AHRQ) has released a new guide to help hospitals better prepare patients to take care of themselves…

Hospira infusers recalled

On Sept. 10, the U.S. Food and Drug Administration announced the recall of the Hospira Symbiq One-Channel and Two-Channel Infusers because of the potential…

How to revive the FDA

The Oct. 6 New England Journal of Medicine includes a perspective on how to “revive” the U.S. Food and Drug Administration. Read…

Hospira infusers recalled

On Sept. 10, the U.S. Food and Drug Administration announced the recall of the Hospira Symbiq One-Channel and Two-Channel Infusers because of…

Test Your Knowledge

Cannabis TYK

Which of the following best explains why clinicians face challenges in discussing medicinal marijuana with their patients?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.